These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11835639)

  • 21. Effect of sirolimus-eluting stent in diabetic patients with small coronary arteries (a SES-SMART substudy).
    Ortolani P; Ardissino D; Cavallini C; Bramucci E; Indolfi C; Aquilina M; Marzocchi A
    Am J Cardiol; 2005 Nov; 96(10):1393-8. PubMed ID: 16275185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute and long-term clinical and angiographic outcome after S-Stent implantation: S-Stent multicenter safety and efficacy trial.
    Chan C; Lim YL; Santoso T; Tresukosol D; Lim YT; Sonoda S; Fitzgerald P
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):439-44. PubMed ID: 15274151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stent thrombosis after sirolimus- and paclitaxel-eluting stent implantation in daily clinical practice: analysis of a single center registry.
    Trabattoni D; Fabbiocchi F; Montorsi P; Ravagnani P; Galli S; Teruzzi G; Calligaris G; De Martini S; Bartorelli AL
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):415-21. PubMed ID: 17722020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Six months' clinical and angiographic follow-up of a flexible, coiled stainless steel stent in long, native coronary artery lesions.
    Thuesen L; Andersen HR; Krusell LR; Kristensen SD
    Scand Cardiovasc J; 2000; 34(2):182-5. PubMed ID: 10872707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.
    Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R;
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry.
    Hoppmann P; Kufner S; Cassese S; Wiebe J; Schneider S; Pinieck S; Scheler L; Bernlochner I; Joner M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):822-9. PubMed ID: 26708019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and angiographic follow-up in patients with Cypher or Taxus stents in populations with high percentage of trial-excluded lesions.
    López-Mínguez JR; Nogales JM; Morales A; Alonso R; González R; Merchán A
    Cardiovasc Revasc Med; 2005; 6(3):92-8. PubMed ID: 16275604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
    Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The low pressure stent observational trial on the procedural and mid-term outcome of a trapezoid-shaped coronary stent (LOPSTER).
    Unverdorben M; Degenhardt R; Wagner E; Koehler H; Scholz M; Unverdorben S; Berthold HK; Vallbracht C
    J Interv Cardiol; 2005 Oct; 18(5):323-9. PubMed ID: 16202106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Description of Pantera Lux paclitaxel-releasing balloon and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis.
    Hehrlein C; Richardt G; Wiemer M; Schneider H; Naber C; Hoffmann E; Dietz U
    EuroIntervention; 2011 May; 7 Suppl K():K119-24. PubMed ID: 22027721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
    Wöhrle J; Werner GS
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metallic Limus-Eluting Stents Abluminally Coated with Biodegradable Polymers: Angiographic and Clinical Comparison of a Novel Ultra-Thin Sirolimus Stent Versus Biolimus Stent in the DESTINY Randomized Trial.
    Lemos PA; Abizaid AA; Meireles GC; Sarmento-Leite R; Prudente M; Cantarelli M; Dourado AD; Mariani J; Perin MA; Costantini C; Costa RA; Costa JR; Chamie D; Campos CA; Ribeiro E
    Cardiovasc Ther; 2015 Dec; 33(6):367-71. PubMed ID: 26352896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thin strut chrome-cobalt stent implantation for treatment of de-novo lesions in small coronary vessels: results of the RISICO Italian Registry (Registro Italiano Mini VISION nei piccolo Vasi) utilizing the Mini VISION coronary stent platform.
    Brambilla N; Morici N; Bedogni F; De Benedictis M; Scrocca I; Naldi M; Fiscella A; Prosperi F; Dominici M; Rebuzzi A; Colombo A; Sangiorgi GM;
    J Cardiovasc Med (Hagerstown); 2009 Nov; 10(11):852-8. PubMed ID: 19550353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
    Stone GW; Goldberg S; O'Shaughnessy C; Midei M; Siegel RM; Cristea E; Dangas G; Lansky AJ; Mehran R
    JACC Cardiovasc Interv; 2011 Mar; 4(3):300-9. PubMed ID: 21435608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiographic and clinical follow-up after coronary implantation of the ACS Multilink Duet stent: a single center experience.
    Sayin T; Berkalp B; Akyürek O; Kervancioğlu C; Oral D
    Jpn Heart J; 2001 Jul; 42(4):409-16. PubMed ID: 11693277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.
    Rensing BJ; Vos J; Smits PC; Foley DP; van den Brand MJ; van der Giessen WJ; de Feijter PJ; Serruys PW
    Eur Heart J; 2001 Nov; 22(22):2125-30. PubMed ID: 11686669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of everolimus-eluting stent with a bioresorbable polymer coating for treatment of recurrent in-stent restenosis.
    Honda H; Meguro T; Takizawa K; Isoyama S
    J Invasive Cardiol; 2005 Feb; 17(2):112-5. PubMed ID: 15687539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial and follow-up results of the BiodivYsio phosphorylcholine coated stent for treatment of coronary artery disease.
    Shinozaki N; Yokoi H; Iwabuchi M; Nosaka H; Kadota K; Mitsudo K; Nobuyoshi M
    Circ J; 2005 Mar; 69(3):295-300. PubMed ID: 15731534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized comparison of J&J Crown stent versus NIR stent after routine coronary angioplasty.
    Miketic S; Carlsson J; Tebbe U
    Am Heart J; 2001 Nov; 142(5):E8. PubMed ID: 11685183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.